Heart rate variability in white-coat hypertension

ObjectivesThe objective of this study was to compare heart rate variability (HRV) in patients with essential hypertension, in patients with white-coat hypertension and in normotensive control individuals, and to investigate a possible relation between HRV and vasoactive hormones. MethodsPatients with essential hypertension (n=19, 61 years, median and interquartile range: 40–66 years), patients with white-coat hypertension (n=8, 52 years, median and interquartile range: 41–64 years) and normotensive participants (n=13, 50 years, median and interquartile range: 39–57 years) participated in the study. HRV was measured at rest in the supine position, during standing and during controled forced breathing (respiration frequency >20/min). Power spectral density was calculated using Fourier transformation. ResultsControled breathing caused a decrease in low frequency (LF) variation and LF/high frequency variation (LF/HF) in all blood pressure groups. The decrease in LF was smaller in the hypertensive group (−60 ms2) than in the normotensive group (−139 ms2) (P=0.03; hypertensive group vs. normotensive group). The decrease in LF/HF induced by controled breathing was −0.9 ms2 in the hypertensive group, −2.0 ms2 in the white-coat hypertensive group and −2.8 ms2 in the normotensive group, (P=0.037; hypertensive group vs. normotensive group). We found a positive correlation between baseline plasma renin concentration and LF (r=0.330, P=0.037) and LF/HF (r=0.378, P=0.016) at rest. ConclusionThe observed differences in HRV might reflect the impaired responsiveness to autonomic challenge in hypertensive patients. We did not find the HRV spectrum in white-coat hypertension different from the HRV spectrum in hypertension or normotension.

[1]  S. Narayan,et al.  CARDIOVASCULAR AUTONOMIC REGULATION IN SUBJECTS WITH NORMAL BLOOD PRESSURE, HIGH–NORMAL BLOOD PRESSURE and RECENT‐ONSET HYPERTENSION , 2005, Clinical and experimental pharmacology & physiology.

[2]  S. Manuck,et al.  White-coat hypertension and autonomic nervous system dysregulation. , 2005, American journal of hypertension.

[3]  H Helenius,et al.  Reduced heart rate variability in hypertension: associations with lifestyle factors and plasma renin activity , 2003, Journal of Human Hypertension.

[4]  A. Malliani,et al.  Impairment in Cardiac Autonomic Regulation Preceding Arterial Hypertension in Humans: Insights From Spectral Analysis of Beat-by-Beat Cardiovascular Variability , 2002, Circulation.

[5]  K. Chayama,et al.  Non-dipper phenomenon in essential hypertension is related to blunted nocturnal rise and fall of sympatho-vagal nervous activity and progress in retinopathy , 2001, Autonomic Neuroscience.

[6]  Importance of compassion , 2001, BMJ : British Medical Journal.

[7]  F. Cuccurullo,et al.  Twenty-four-hour autonomic nervous function in sustained and "white coat" hypertension. , 2000, American heart journal.

[8]  G. Mancia,et al.  Blood Pressure Monitoring. Task force V: White-coat hypertension. , 1999, Blood pressure monitoring.

[9]  G. Mancia,et al.  Task force V: White-coat hypertension , 1999 .

[10]  J. Taylor,et al.  Controlled breathing protocols probe human autonomic cardiovascular rhythms. , 1998, American journal of physiology. Heart and circulatory physiology.

[11]  P. Ivarsen,et al.  A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. , 1997, Scandinavian journal of clinical and laboratory investigation.

[12]  Frisina,et al.  Frequency domain of heart rate and blood pressure variability in essential hypertensive patients during sleep: differences between dippers and non-dippers. , 1996, Blood pressure monitoring.

[13]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[14]  E. Bruce,et al.  Override of spontaneous respiratory pattern generator reduces cardiovascular parasympathetic influence. , 1995, Journal of applied physiology.

[15]  J. De Sutter,et al.  Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension. , 1995, American journal of hypertension.

[16]  D L Eckberg,et al.  Voluntary control of breathing does not alter vagal modulation of heart rate. , 1995, Journal of applied physiology.

[17]  I. Reid.  Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. , 1992, The American journal of physiology.

[18]  Yu-heng Zhang,et al.  Theoretical issues for critical currents of bulk polycrystalline YBa2Cu3O7−δ superconductors , 1989 .

[19]  D. Seals,et al.  Influence of physical training on heart rate variability and baroreflex circulatory control. , 1989, Journal of applied physiology.

[20]  S Cerutti,et al.  Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. , 1988, Journal of hypertension.

[21]  J. Laragh,et al.  How common is white coat hypertension? , 1988, JAMA.

[22]  T. Nielsen,et al.  Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. , 1987, International journal of cardiology.

[23]  M. Turiel,et al.  Power Spectral Analysis of Heart Rate and Arterial Pressure Variabilities as a Marker of Sympatho‐Vagal Interaction in Man and Conscious Dog , 1986, Circulation research.

[24]  A. Kappelgaard,et al.  Measurement of angiotensin II in human plasma: technical modifications and practical experience. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[25]  G D Pinna,et al.  Effect of paced breathing on ventilatory and cardiovascular variability parameters during short-term investigations of autonomic function. , 2006, American journal of physiology. Heart and circulatory physiology.

[26]  H. Danielsen,et al.  Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension , 2004, European Journal of Clinical Pharmacology.

[27]  M. Malik.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996, European heart journal.

[28]  H. Rüddel,et al.  Reduced parasympathetic cardiac control in patients with hypertension at rest and under mental stress. , 1994, American heart journal.

[29]  H. Danielsen,et al.  Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.